AST-301 - University of Washington, Aston Sci., EpiThany
Keytruda (pembrolizumab) - Merck (MSD)
https://www.abstractsonline.com/pp8/#!/10828/presentation/4032
 
Hyo-Hyun Park1; Hye-Ran Kim2; Jin Kyeong Choi3; Jee Hyun Choi1; JinHo Kang1; Jinback Lim1; Hyo Jung Lim3; Jong Yeong Lee3; Eunkyo Joung4; Hun Jung4
 
Mar 14, 2023
 
Prev Next